Literature DB >> 19543296

Diabetes: Aspirin and prevention of diabetes still a topic of debate.

Guido Lastra, Adam Whaley-Connell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19543296     DOI： 10.1038/nrendo.2009.109

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

1.  Prevention of fat-induced insulin resistance by salicylate.

Authors:  J K Kim; Y J Kim; J J Fillmore; Y Chen; I Moore; J Lee; M Yuan; Z W Li; M Karin; P Perret; S E Shoelson; G I Shulman
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  Acetylsalicylic acid improves lipid-induced insulin resistance in healthy men.

Authors:  Matthias Möhlig; Madlen Freudenberg; Thomas Bobbert; Michael Ristow; Helmut Rochlitz; Martin O Weickert; Andreas F H Pfeiffer; Joachim Spranger
Journal:  J Clin Endocrinol Metab       Date:  2005-12-29       Impact factor: 5.958

3.  Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes.

Authors:  Ripudaman S Hundal; Kitt F Petersen; Adam B Mayerson; Pritpal S Randhawa; Silvio Inzucchi; Steven E Shoelson; Gerald I Shulman
Journal:  J Clin Invest       Date:  2002-05       Impact factor: 14.808

4.  Aspirin inhibits serine phosphorylation of insulin receptor substrate 1 in tumor necrosis factor-treated cells through targeting multiple serine kinases.

Authors:  Zhanguo Gao; Aamir Zuberi; Michael J Quon; Zigang Dong; Jianping Ye
Journal:  J Biol Chem       Date:  2003-04-24       Impact factor: 5.157

5.  Insulin therapy is associated with platelet dysfunction in patients with type 2 diabetes mellitus on dual oral antiplatelet treatment.

Authors:  Dominick J Angiolillo; Esther Bernardo; Celia Ramírez; Marco A Costa; Manel Sabaté; Pilar Jimenez-Quevedo; Rosana Hernández; Raul Moreno; Javier Escaned; Fernando Alfonso; Camino Bañuelos; Theodore A Bass; Carlos Macaya; Antonio Fernandez-Ortiz
Journal:  J Am Coll Cardiol       Date:  2006-06-22       Impact factor: 24.094

6.  Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men.

Authors:  P M Ridker; M Cushman; M J Stampfer; R P Tracy; C H Hennekens
Journal:  N Engl J Med       Date:  1997-04-03       Impact factor: 91.245

7.  Aspirin use and risk of type 2 diabetes in apparently healthy men.

Authors:  Yasuaki Hayashino; Charles H Hennekens; Tobias Kurth
Journal:  Am J Med       Date:  2009-02-21       Impact factor: 4.965

Review 8.  Aspirin and Diabetes Mellitus: revisiting an old player.

Authors:  Camila Manrique; Guido Lastra; John Palmer; Michael Gardner; James R Sowers
Journal:  Ther Adv Cardiovasc Dis       Date:  2008-02

Review 9.  Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance.

Authors:  S E Shoelson; J Lee; M Yuan
Journal:  Int J Obes Relat Metab Disord       Date:  2003-12

10.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.